Reduced Platelet MAO-B Activity Is Associated with Psychotic, Positive, and Depressive Symptoms in PTSD
-
Published:2022-05-23
Issue:5
Volume:12
Page:736
-
ISSN:2218-273X
-
Container-title:Biomolecules
-
language:en
-
Short-container-title:Biomolecules
Author:
Repovecki Senka1, Nedic Erjavec Gordana2ORCID, Uzun Suzana13, Tudor Lucija2, Nikolac Perkovic Matea2ORCID, Konjevod Marcela2, Kozumplik Oliver1, Svob Strac Dubravka2ORCID, Kovacic Petrovic Zrnka1, Mimica Ninoslav13, Pivac Nela2
Affiliation:
1. University Psychiatric Hospital Vrapce, 10000 Zagreb, Croatia 2. Laboratory for Molecular Neuropsychiatry, Division of Molecular Medicine, Ruder Boskovic Institute, 10000 Zagreb, Croatia 3. School of Medicine, University of Zagreb, 10000 Zagreb, Croatia
Abstract
Post-traumatic stress disorder (PTSD) is a trauma-related disorder. Platelet monoamine oxidase (MAO-B) is a peripheral biomarker associated with various symptoms in different psychopathologies, but its role in PTSD or different symptoms in PTSD is not clear. This study elucidated the association between platelet MAO-B activity and clinical symptoms occurring in PTSD. Platelet MAO-B activity was determined in 1053 male Caucasian subjects: 559 war veterans with PTSD (DSM-5 criteria), 62 combat exposed veterans who did not develop PTSD, and 432 non-combat exposed healthy controls. Clinical symptoms in PTSD were determined using CAPS and PANSS. Platelet MAO-B activity, controlled for the effect of smoking, was significantly increased in PTSD with severe versus mild and moderate traumatic symptoms, and was significantly decreased in PTSD subjects with severe versus mild positive, psychotic, and depressive symptoms. This finding was further confirmed with reduced platelet MAO-B activity in PTSD veterans with severe versus mild individual items of the PANSS-depressed, PANSS-psychotic, and PANSS-positive subscales. Altered platelet MAO-B activity, controlled for the possible confounders, was associated with the development and severity of different symptoms occurring in PTSD. These findings confirmed the role of platelet MAO-B activity as a peripheral marker of various psychopathological symptoms.
Funder
Croatian Science Foundation
Reference77 articles.
1. American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. [5th ed.]. 2. Trauma and PTSD in the WHO World Mental Health Surveys;Kessler;Eur. J. Psychotraumatol.,2017 3. Mellon, S.H., Bersani, F.S., Lindqvist, D., Hammamieh, R., Donohue, D., Dean, K., Jett, M., Yehuda, R., Flory, J., and Reus, V.I. (2019). Metabolomic analysis of male combat veterans with post traumatic stress disorder. PLoS ONE, 14. 4. Tudor, L., Erjavec, G.N., Perkovic, M.N., Konjevod, M., Strac, D.S., Uzun, S., Kozumplik, O., Jovanovic, T., Lauc, G., and Pivac, N. (2019). N-glycomic Profile in Combat Related Post-Traumatic Stress Disorder. Biomolecules, 9. 5. Endocrine aspects of post-traumatic stress disorder and implications for diagnosis and treatment;Daskalakis;Endocrinol. Metab. Clin. N. Am.,2013
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|